TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • ✓200 free stock & ETF trades
  • ✓Unlimited commission-free trades on 180+ select ETFs
  • ✓Offer ends September 30, 2026
Stocks/NASDAQ/YDES

YD Bio Ltd (YDES : NASDAQ)

Common Stock

$4.77

USD

+1.54 (47.68%)

Last updated: 2026-09-24

Follow YDES

YDES

YD Bio Ltd

Source:WealthAwesomeWealthAwesome
↑ $2.26 (90.04%)
30 day period
$2.51$3.65$4.80Aug 13Sep 3Sep 24

Performance

1 Day

+47.68%

1 Week

+47.22%

1 Month

+1.92%

YTD

+89.29%

Key Statistics

Market Cap

$337.87M

52W High

$22.00

52W Low

$1.70

P/E Ratio

0.00

50 Day MA

$3.23

200 Day MA

$6.31

Beta

-0.03

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/24/2026$3.26$5.41$3.26$4.77$4.773,124,455
9/23/2026$2.78$3.34$2.42$3.23$3.23359,003
9/22/2026$2.67$3.10$2.60$2.82$2.82390,344
9/21/2026$3.11$3.35$2.51$2.63$2.63662,570
9/18/2026$3.25$3.57$3.15$3.19$3.19535,500
9/17/2026$3.70$3.76$3.12$3.24$3.24542,641
9/16/2026$3.90$3.90$3.27$3.70$3.70695,121
9/15/2026$3.79$4.04$3.66$3.95$3.95688,666
9/14/2026$4.01$4.01$3.61$3.83$3.83523,342
9/11/2026$3.93$4.19$3.61$4.00$4.00819,273

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on YDES's historical volatility

HistoricalForecast68%95%
US$0.47US$14.27US$28.06US$41.86US$55.66US$69.46TodayJun 17Aug 6Sep 24Nov 6Dec 20Feb 1

30-Day Vol

206.7%

Annualized

90-Day Vol

164.4%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$5.70

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$5.06US$2.48 – US$10.33
60 trading daysUS$5.37US$1.96 – US$14.73
90 trading daysUS$5.70US$1.66 – US$19.61

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About YD Bio Ltd

YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate symptoms of dry eye syndrome, including irritation, foreign body sensation, and eye fatigue; and LSC Eye Drug/Injection, an injectable ophthalmic drug is being developed for the treatment of various retinal and macular disorders, such as age-related macular degeneration, macular edema, choroidal and subretinal neovascularization, and neovascular glaucoma. It also provides Hydrogel (Hioxifilcon A) Soft (Hydrophilic) Contact Lens, a spherical and aspherical lenses. In addition, the company supplies drugs and medical materials for clinical trials; and operates DNA methylation-based oncology testing programs. Further, it provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination, and compliance-focused support for clinical development programs to pharmaceutical and biotechnology companies. It serves corporate and retail customers. The company was founded in 2013 and is based in Taipei, Taiwan.

Financials

Revenue (TTM)
$1.24M
EBITDA
$-6.34M
Profit Margin
24.67%
ROE (TTM)
-42.69%
EPS (Diluted)
0.00
Book Value
4.57

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About YDES.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
RPGLRepublic Power Group Limited Class A Ordinary Shares$14.69+1363.23%
KITTNauticus Robotics Inc.$2.93+459.21%
ZWZZTNASDAQ TEST STOCK$24.50+144.51%
SRZNSurrozen Inc$33.68+108.42%
GLNDGreenland Energy Company Common Stock$5.35+83.85%
PMAXPowell Max Limited Class A Ordinary Shares$1.65+80.62%
STAKSTAK Inc. Ordinary Shares$1.44+53.19%
PFSAProfusa, Inc. Common Stock$3.03+47.80%

Advertisement